A pilot/phase II study evaluating perbrolizumab plus standard-of-care Chemotherapy in metastatic triple-negative breast cancer, with companion comprehensive immunological monitoring
Publication Title
Soceity for Immunotherapy of Cancer Poster: Nov 2016, MD
Document Type
Presentation
Publication Date
1-1-2016
Keywords
psvmc gme
Abstract
2016-2017 PGY2
Specialty/Research Institute
Graduate Medical Education
